Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Straumann targets Italian growth with BIO buy

This article was originally published in Clinica

Swiss dental products maker Straumann is to acquire BIO, its exclusive distributor in Italy. The Waldenburg-based specialist in dental implants and tissue regeneration products says the takeover of Milan-based BIO will help it "unlock further potential in the Italian market".

BIO's 30-person business, which operates through a network of sales agents, focuses primarily on Straumann's products. Straumann says that while the existing operations are "excellently run" and have grown strongly, its own scale and resources should enable further sales expansion.

BIO's CEO, Simo Beraha, will continue to run the business under the title of country manager, while Mirella Beraha will continue as head of marketing.

Italy is Straumann's second largest European market after Germany. The group reported total sales of SwFr344m ($296m) in 2003, and net income of SwFr80m.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel